G6PD and melanoma: To test whether melanoma metastasis depended on the oxidative pentose phosphate pathway, we used CRISPR to make small deletions in exon 6 of G6PD in three melanomas including the A375 human melanoma cell line and two patient-derived melanomas (M481 and M214).